Your browser doesn't support javascript.
loading
The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver Tissue.
Akiba, Jun; Yoshida, Takafumi; Sadashima, Eiji; Murata, Kazuya; Matsui, Takanori; Yamagishi, Sho-Ichi; Kusano, Hironori; Mihara, Yutaro; Mizuochi, Shinji; Kinjou, Yoshinao; Naito, Yoshiki; Hisaka, Toru; Sakai, Hisamune; Okuda, Koji; Nakashima, Osamu; Yano, Hirohisa.
Afiliação
  • Akiba J; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan; akiba@med.kurume-u.ac.jp.
  • Yoshida T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Sadashima E; Life Science Research Institute, Saga-ken Medical Centre Koseikan, Saga, Japan.
  • Murata K; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.
  • Matsui T; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
  • Yamagishi SI; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kusano H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Mihara Y; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Mizuochi S; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Kinjou Y; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Naito Y; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan.
  • Hisaka T; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Sakai H; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Okuda K; Department of Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Nakashima O; Department of Clinical Laboratory Medicine, Kurume University Hospital, Kurume, Japan.
  • Yano H; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
Anticancer Res ; 41(3): 1203-1212, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33788711
ABSTRACT
BACKGROUND/

AIM:

Hepatocellular carcinoma (HCC) remains one of the biggest medical issues. Pigment epithelial-derived factor (PEDF) is a glycoprotein that belongs to the superfamily of serine protease inhibitors. PEDF interacts with its two receptors, adipose triglyceride lipase (ATGL) and laminin receptor (LR). MATERIALS AND

METHODS:

We conducted immunohistochemical staining for PEDF, LR and ATGL in 151 resected HCCs and their background liver tissues.

RESULTS:

High expression of LR in HCC was associated with high histological grade and portal vein invasion, while high expression of PEDF in HCC was associated with absence of portal vein invasion. High LR expression in background liver was statistically associated with low serum albumin levels and was an independent prognostic factor of worse outcomes. No cases with more than 5% fatty degeneration in the background liver tissue showed high PEDF expression.

CONCLUSION:

PEDF/LR/ATGL could be potential biomarkers in HCC and various chronic hepatic disorders.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serpinas / Receptores de Laminina / Receptores de Neuropeptídeos / Carcinoma Hepatocelular / Proteínas do Olho / Lipase / Fígado / Neoplasias Hepáticas / Fatores de Crescimento Neural Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Serpinas / Receptores de Laminina / Receptores de Neuropeptídeos / Carcinoma Hepatocelular / Proteínas do Olho / Lipase / Fígado / Neoplasias Hepáticas / Fatores de Crescimento Neural Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Anticancer Res Ano de publicação: 2021 Tipo de documento: Article